BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

59.07

-1.25 (-2.07%)

At close: Mar 12, 2026, 4:00 PM EDT

58.53

-0.54 (-0.92%)

After-hours: Mar 12, 2026, 6:25 PM EDT

BioMarin Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,312	942.84	755.13	724.53	587.28
Short-Term Investments	248.93	194.86	318.68	567.01	426.6
Cash & Short-Term Investments	1,561	1,138	1,074	1,292	1,014
Cash Growth	37.17%	5.95%	-16.86%	27.39%	-4.83%
Accounts Receivable	908.21	660.54	633.7	461.32	373.4
Inventory	1,299	1,233	1,107	894.08	776.67
Other Current Assets	185.78	201.53	141.39	104.52	110.44
Total Current Assets	3,953	3,232	2,956	2,751	2,274
Net Property, Plant & Equipment	952.51	1,043	1,066	1,073	1,035
Other Intangible Assets	213.84	255.28	294.7	338.57	388.65
Goodwill	196.2	196.2	196.2	196.2	196.2
Long-Term Investments	492.24	521.24	611.14	333.84	507.79
Other Long-Term Assets	1,786	1,741	1,717	1,682	1,602
Total Assets	7,594	6,989	6,842	6,375	6,005
Accounts Payable	759.03	606.99	683.15	572.96	498.27
Short-Term Debt	-	-	493.88	-	-
Other Current Liabilities	-	-	-	15.93	48.23
Total Current Liabilities	759.03	606.99	1,177	588.88	546.5
Long-Term Debt	597.18	595.14	593.1	1,083	1,079
Other Long-Term Liabilities	150.82	128.82	119.94	100.02	113.53
Total Long-Term Liabilities	747.99	723.96	713.03	1,183	1,193
Total Liabilities	1,507	1,331	1,890	1,772	1,739
Common Stock	0.19	0.19	0.19	0.19	0.18
Treasury Stock	-10.51	-11.23	-9.86	-8.86	-9.69
Additional Paid-in Capital	5,957	5,802	5,612	5,405	5,192
Accumulated Other Comprehensive Income	-13.47	61.65	-28.79	-3.87	14.43
Retained Earnings	154.21	-194.7	-621.55	-789.2	-930.76
Shareholders' Equity	6,087	5,658	4,952	4,603	4,266
Total Liabilities & Equity	7,594	6,989	6,842	6,375	6,005
Total Debt	597.18	595.14	1,087	1,083	1,079
Net Cash (Debt)	963.43	542.57	-13.16	208.52	-65.2
Net Cash Growth	77.57%	-	-	-	-
Net Cash Per Share	4.88	2.76	-0.07	1.10	-0.36
Book Value	6,087	5,658	4,952	4,603	4,266
Book Value Per Share	30.84	28.76	25.84	24.36	23.33
Tangible Book Value	5,677	5,207	4,461	4,068	3,681
Tangible Book Value Per Share	28.76	26.47	23.28	21.53	20.13

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q